Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticholinergic agents

M Cazzola1, S Centanni, C F Donner

  • 1S. Maugeri Foundation, Institute of Care and Research, Medical Centre of Rehabilitation, Clinical Pharmacology Unit and Respiratory Pharmacology Centre, Veruno, Italy. mcazzola@qubisoft.it

Pulmonary Pharmacology & Therapeutics
|April 22, 1999
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study of correlation between forced vital capacity and demand for healthcare services in severe asthmatics.

Multidisciplinary respiratory medicine·2015
Same author

The clinical and integrated management of COPD.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2014
Same author

Leukemia risk models in primary myelofibrosis: an International Working Group study.

Leukemia·2012
Same author

Chronic widespread pain and fibromyalgia: could there be some relationships with infections and vaccinations?

Clinical and experimental rheumatology·2012
Same author

Psychometric properties of the Fibromyalgia Assessment Status (FAS) index: a national web-based study of fibromyalgia.

Clinical and experimental rheumatology·2011
Same author

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.

The New England journal of medicine·2011
Same journal

Brain-Derived Neurotrophic Factor (BDNF) Signaling in Respiratory Disease: Mechanisms, Neuroimmune Crosstalk, and Therapeutic Implications.

Pulmonary pharmacology & therapeutics·2026
Same journal

PD05, a novel neutrophil elastase inhibitor, mitigates LPS-induced acute lung injury in a preclinical model.

Pulmonary pharmacology & therapeutics·2026
Same journal

The preclinical discovery and development of depemokimab for severe eosinophilic asthma.

Pulmonary pharmacology & therapeutics·2026
Same journal

TROP2 as a promising therapeutic target in lung cancer: Current clinical trial landscape and future directions.

Pulmonary pharmacology & therapeutics·2026
Same journal

Synergistic induction of apoptosis in lung cancer cells via TOP2A targeting through combined dihydroartemisinin and chrysin treatment.

Pulmonary pharmacology & therapeutics·2026
Same journal

Evodiamine protects against lung ischemia-reperfusion injury by attenuating SYK-associated TLR4/NLRP3 inflammasome activation and ferroptosis-related injury signatures.

Pulmonary pharmacology & therapeutics·2026
See all related articles